Elucidating the exact pharmacological mechanism of action (MOA) of naturally occurring compounds can be challenging. Although Tarselli et al. (60) developed the main de novo artificial pathway to conolidine and showcased that this naturally happening compound efficiently suppresses responses to both chemically induced and inflammation-derived pain, the pharmacologic focus https://nicolausp864mor5.wikidank.com/user